Established marketing expert and notable leader in the real estate industry Boris Mizhen has generously contributed to support medical science, research and practice at Connecticut’s Yale-New Haven Hospital, the top institute for oncology, transplantation and pediatrics in New England. Throughout his career, he has remained a considerable financial contributor towards both national charitable organizations and to local non-profits in the eastern Tri-State area. Yale-New Haven is the second-largest employer in Connecticut and ranked as one of the top hospitals in the nation by US News & World Report.
“I’m very happy to give my financial assistance to the Yale-New Haven Hospital,” said Boris Mizhen. “For nearly two hundred years, the facility has been caring for the health of New England’s population in extraordinary ways. The hospital’s achievements include dozens of major medical breakthroughs, which have benefitted the entire world. I hope that my donation may contribute in at least a small way in their hugely positive work.”
Yale-New Haven Hospital was founded in 1826 as the General Hospital Society of Connecticut. Originally opened as a charitable institution caring for the poor, it soon expanded its scope to include the entire community. In particular, it helped many sailors from New Haven’s busy seaport and during the Civil War, more than 25,000 Union soldiers were treated there. The Yale School of Medicine formalized its relationship with the hospital in 1913, developing a formal educational training program that served as the model to many teaching hospitals, to ultimately become the “Yale-New Haven Medical Center.”
Boris Mizhen is proud to sponsor such a historic and famous institution and is excited to witness what further developments it will achieve in its future. Yale-New Haven Hospital boasts an impressive list of accomplishments in regards to its performance within the United States. It is the site for the first recorded use of medical X-Ray in 1896 and the first clinical distribution of penicillin in 1942. When chemotherapy was introduced on to its campus, it became the first place in the country to offer the treatment to its patients. It successfully identified and named Lyme disease in 1975 and produced the first insulin infusion pump for diabetics a year later. The nation’s initial fetal cardiovascular center was built there in 1985, and in 2002 it was recognized as the first US hospital to transplant nerve cells into the brain of a multiple sclerosis patient.
Boris Mizhen was a longtime resident of Guilford, Connecticut, which has instilled a particular affinity for the New England area and its many philanthropic organizations that have received his support. He now resides in New York City where he leads a successful real estate development company. Through the Boris Mizhen Family Trust, he has expressed his support to a huge number of local and national charities including the Jewish Foundation of Greater New Haven and the Chabad of Shoreline’s Jacob Fund. Mizhen dedicates considerable time to helping residents displaced by gentrification and towards making the sometimes inevitable neighborhood transition less destructive to the original character of a community.